Acelyrin, Inc. (NASDAQ: SLRN)
$3.1900
-0.0300 ( +0.31% ) 429.3K
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
Market Data
Open
$3.1900
Previous close
$3.2200
Volume
429.3K
Market cap
$314.02M
Day range
$3.1110 - $3.3000
52 week range
$3.1100 - $8.8850
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 74 | May 14, 2024 |
| 8-k | 8K-related | 16 | May 09, 2024 |
| def | Proxies and info statements | 3 | Apr 22, 2024 |
| ars | Annual reports | 1 | Apr 22, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 8-k | 8K-related | 14 | Mar 28, 2024 |
| 10-k | Annual reports | 104 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 20, 2024 |
| 8-k | 8K-related | 48 | Mar 11, 2024 |
| 4 | Insider transactions | 1 | Feb 22, 2024 |